ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Jan 23, 2004
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
SCOTT ROBERT A
Sr VP Clinical Dev & RA
Transactions
- Exercise/Conversion
Common stock
2004-01-21$7.04/sh+4,800$33,792→ 26,400 total - Exercise/Conversion
Incentive stock option (Right to buy)
2004-01-21−7,500→ 22,500 totalExercise: $7.41Exp: 2012-12-31→ Common stock (7,500 underlying) - Exercise/Conversion
Incentive stock option (Right to buy)
2004-01-21−4,800→ 53,600 totalExercise: $7.04Exp: 2012-08-30→ Common stock (4,800 underlying) - Exercise/Conversion
Common stock
2004-01-21$7.41/sh+7,500$55,575→ 33,900 total
Footnotes (2)
- [F1]25% of these options vested on 8/30/03, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.
- [F2]25% of these options vested on 12/31/03, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.